Vertex Pharmaceuticals Reaches Analyst Target Price
1/5 16:48
In recent trading, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $509.33, changing hands for $509.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: do...